Covered recipient · General Payments record
HOLLY BOWMAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,623.18
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $379.56 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.94 | 11 |
| Lilly USA, LLC | $110.90 | 1 |
| Novo Nordisk AS | $62.93 | 3 |
| Lundbeck LLC | $23.07 | 1 |
| Astellas Pharma US Inc | $19.04 | 1 |
| Abbott Laboratories | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.68 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125088794 | CMS |
| ABBVIE INC. | $18.75 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807912 | CMS |
| ABBVIE INC. | $13.55 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807914 | CMS |
| ABBVIE INC. | $13.51 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807916 | CMS |
| ABBVIE INC. | $16.48 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807918 | CMS |
| ABBVIE INC. | $12.43 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807920 | CMS |
| ABBVIE INC. | $15.75 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807922 | CMS |
| ABBVIE INC. | $13.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807924 | CMS |
| ABBVIE INC. | $11.33 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807926 | CMS |
| ABBVIE INC. | $7.43 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807928 | CMS |
| ABBVIE INC. | $10.62 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807930 | CMS |
| ABBVIE INC. | $15.13 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106807932 | CMS |
| Astellas Pharma US Inc | $19.04 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139496620 | CMS |
| Lilly USA, LLC | $110.90 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135679725 | CMS |
| Lundbeck LLC | $23.07 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145997303 | CMS |
| Novo Nordisk Inc | $15.43 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100581502 | CMS |
| Novo Nordisk Inc | $23.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370415 | CMS |
| Novo Nordisk Inc | $23.71 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100574546 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.